The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Drug‐induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies
Abstract
Drug ototoxicity limits the quality of life of patients after treatment, having serious consequences, especially for psychosocial development of children. Although the ototoxicity of many drugs resolves after treatment discontinuation, the use of platinum derivatives and aminoglycosides is associated with permanent hearing loss. In this review, we have listed ototoxic drugs and the mechanisms by which they damage the ears. Moreover, possible protective strategies and important methods for early detection of ototoxic effects are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Baguley, D., McFerran, D., & Hall, D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60142-7 · Cited by 1,245
Prezant, T. R., Agapian, J. V., Bohlman, M. C., Bu, X., Öztas, S., Qiu, W.-Q., Arnos, K. S., Cortopassi, G. A., Jaber, L., Rotter, J. I., et al. (1993) · Nature Genetics · doi:10.1038/ng0793-289 · Cited by 1,196
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J. K., Baliraine, F. N., Rosenthal, P. J., & D'Alessandro, U. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-144 · Cited by 1,007
Platinum-based drugs: past, present and future
Dilruba, S., & Kalayda, G. V. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-2976-z · Cited by 906
Mechanisms of cisplatin-induced ototoxicity and prevention
Rybak, L. P., Whitworth, C. A., Mukherjea, D., & Ramkumar, V. (2007) · Hearing Research · doi:10.1016/j.heares.2006.09.015 · Cited by 563
Knight, K. R. G., Kraemer, D. F., & Neuwelt, E. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5355 · Cited by 542
Cochlear Outer Hair Cell Motility
Ashmore, J. (2008) · Physiological Reviews · doi:10.1152/physrev.00044.2006 · Cited by 503
Ciarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenstädt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A. H., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090610 · Cited by 444
Self-citationDeafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter
Delpire, E., Lu, J., England, R., Dull, C., & Thorne, T. (1999) · Nature Genetics · doi:10.1038/9713 · Cited by 411
THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE UNITED STATES
Mohr, P. E., Feldman, J. J., Dunbar, J. L., McConkey-Robbins, A., Niparko, J. K., Rittenhouse, R. K., & Skinner, M. W. (2000) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300103162 · Cited by 398
Brock, P. R., Knight, K. R., Freyer, D. R., Campbell, K. C. M., Steyger, P. S., Blakley, B. W., Rassekh, S. R., Chang, K. W., Fligor, B. J., Rajput, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1110 · Cited by 380
Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention
Schacht, J., Talaska, A. E., & Rybak, L. P. (2012) · The Anatomical Record · doi:10.1002/ar.22578 · Cited by 348
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
Howell, S. B., Safaei, R., Larson, C. A., & Sailor, M. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063172 · Cited by 344
New developments in aminoglycoside therapy and ototoxicity
Xie, J., Talaska, A. E., & Schacht, J. (2011) · Hearing Research · doi:10.1016/j.heares.2011.05.008 · Cited by 287
Yang, Z., Schumaker, L. M., Egorin, M. J., Zuhowski, E. G., Guo, Z., & Cullen, K. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1037 · Cited by 267
Auditory sensori-neural alterations induced by salicylate
Cazals, Y. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00027-7 · Cited by 244
Understanding platinum-induced ototoxicity
Langer, T., am Zehnhoff-Dinnesen, A., Radtke, S., Meitert, J., & Zolk, O. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.05.006 · Cited by 243
Tran Ba Huy, P., Bernard, P., & Schacht, J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112463 · Cited by 239
Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity
Avent, M. L., Rogers, B. A., Cheng, A. C., & Paterson, D. L. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02452.x · Cited by 231
Cianfrone, G., Pentangelo, D., Cianfrone, F., Mazzei, F., Turchetta, R., Orlando, M. P., & ALTISSIMI, G. (2011) · PubMed · Cited by 198
Prevalence of mitochondrial gene mutations among hearing impaired patients
Usami, S.-I., Abe, S., Akita, J., Namba, A., Shinkawa, H., Ishii, M., Iwasaki, S., Hoshino, T., Ito, J., Doi, K., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.38 · Cited by 197
Day, B. L., & Fitzpatrick, R. C. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.053 · Cited by 169
Stimulation of free radical formation by aminoglycoside antibiotics
Sha, S.-H., & Schacht, J. (1999) · Hearing Research · doi:10.1016/s0378-5955(98)00200-7 · Cited by 169
Vancomycin Ototoxicity and Nephrotoxicity
Bailie, G. R., & Neal, D. (1988) · Medical Toxicology · doi:10.1007/bf03259891 · Cited by 150
Prevalence of Mitochondrial 1555A→G Mutation in Adults of European Descent
Vandebona, H., Mitchell, P., Manwaring, N., Griffiths, K., Gopinath, B., Wang, J. J., & Sue, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0806397 · Cited by 124
Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses
Forouzesh, A., Moise, P. A., & Sakoulas, G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01088-08 · Cited by 124
Vancomycin- and erythromycin-induced hearing loss in humans
Brummett, R. E., & Fox, K. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.6.791 · Cited by 119
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
Riedemann, L., Lanvers, C., Deuster, D., Peters, U., Boos, J., Jürgens, H., & Zehnhoff‐Dinnesen, A. A. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500455 · Cited by 119
Self-citationOVERVIEW OF PSYCHOLOGIC EFFECTS OF CHRONIC DIZZINESS AND BALANCE DISORDERS
Yardley, L. (2000) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(05)70229-2 · Cited by 118
Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
Hellberg, V., Wallin, I., Eriksson, S., Hernlund, E., Jerremalm, E., Berndtsson, M., Eksborg, S., Arnér, E. S. J., Shoshan, M. C., Ehrsson, H., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn418 · Cited by 113
Hospers, G. A. P., Eisenhauer, E. A., & de Vries, E. G. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690404 · Cited by 109
Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus
Chen, G., Stolzberg, D. J., Lobariñas, E., Sun, W., Ding, D., & Salvi, R. (2012) · Hearing Research · doi:10.1016/j.heares.2012.11.016 · Cited by 106
Future opportunities in preventing cisplatin induced ototoxicity
van den Berg, J. H., Beijnen, J. H., Balm, A. J. M., & Schellens, J. H. M. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.04.011 · Cited by 101
Gatell, J. M., Ferran, F., Araujo, V., Bonet, M., Soriano, E., Traserra, J., & SanMiguel, J. G. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.9.1383 · Cited by 101
Ternary Complexes of Gentamicin with Iron and Lipid Catalyze Formation of Reactive Oxygen Species
Lesniak, W. G., Pecoraro, V. L., & Schacht, J. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0496946 · Cited by 99
Thomas, J. P., Lautermann, J., Liedert, B., Seiler, F., & Thomale, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022244 · Cited by 90
Medical interventions for the prevention of platinum-induced hearing loss in children with cancer
van As, J. W., van den Berg, H., & van Dalen, E. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009219.pub4 · Cited by 85
Olivero, O. A., Chang, P. K., López‐Larraza, D. M., Semino-Mora, M. C., & Poirier, M. C. (1997) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s0165-1218(97)00037-2 · Cited by 83
Brown, B. A., Griffith, D. E., Girard, W., Levin, J., & Wallace, R. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.958 · Cited by 74
Irreversible Sensorineural Hearing Loss as a Result of Azithromycin Ototoxicity: A Case Report
Ress, B. D., & Gross, E. M. (2000) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940010900416 · Cited by 60
Hong, S., Harris, K. A., Fanning, K. D., Sarachan, K. L., Frohlich, K. M., & Agris, P. F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655092 · Cited by 48
Lafay‐Cousin, L., Purdy, E. I., Huang, A., Cushing, S. L., Papaioannou, V. A., Nettel‐Aguirre, A., & Bouffet, É. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24307 · Cited by 33
Vancomycin administration in continuous ambulatory peritoneal dialysis: The risk of ototoxicity
Gendeh, B. S., Gibb, A. G., Aziz, N. S., et al. (1998) · Otolaryngology · doi:10.1177/019459989811800420 · Cited by 30
Medical interventions for the prevention of platinum-induced hearing loss in children with cancer
van As, J. W., van den Berg, H., & van Dalen, E. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009219.pub3 · Cited by 27
Cited by
Use of Zebrafish in Drug Discovery Toxicology
Cassar, S., Adatto, I., Freeman, J. L., Gamse, J. T., Iturria, I., Lawrence, C., Muriana, A., Peterson, R. T., Van Cruchten, S., & Zon, L. I. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00335 · Cited by 561
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Amikacin: Uses, Resistance, and Prospects for Inhibition
Ramirez, M., & Tolmasky, M. (2017) · Molecules · doi:10.3390/molecules22122267 · Cited by 265
Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer
Romano, A., Capozza, M. A., Mastrangelo, S., Maurizi, P., Triarico, S., Rolesi, R., Attinà, G., Fetoni, A. R., & Ruggiero, A. (2020) · Cancers · doi:10.3390/cancers12051266 · Cited by 65
Metadata
- Authors
- Lanvers‐Kaminsky, C., Zehnhoff‐Dinnesen, A. A., Parfitt, R., & Ciarimboli, G.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2017-02-03
- Volume
- 101
- Issue
- 4
- Pages
- 491-500
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2564575422
- Cited by
- 277
- References
- 45
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.